Achtung! Das Lehrangebot ist noch nicht vollständig und wird bis Semesterbeginn laufend ergänzt.
323008 SE Case Studies in Drug Discovery and Preclinical Drug Development - MPS7 (2023S)
(2 Courses)
Prüfungsimmanente Lehrveranstaltung
Labels
Details
Sprache: Englisch
Lehrende
Termine (iCal) - nächster Termin ist mit N markiert
Dates that are missing above (See Moodle for the schedule for each case study):
1st day of the course: Tuesday 02.05.2023 09.00-11.00 Web-based - all Case Studies
Wednesday 03.05.2023 16.00 - 18.00 Web-based (Case Study 1)
Friday 05.05.2023 14.00 - 16.00 Web-based (Case Study 3)
Monday 15.05.2023 13.00 - 15.00 Web-based (Case Study 3)
Thursday 18.05.2023 16.00 - 18.00 Web-based (Case Study 1)
- Freitag 05.05. 09:00 - 11:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Dienstag 16.05. 09:00 - 11:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Mittwoch 31.05. 09:00 - 11:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Montag 05.06. 14:00 - 16:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Dienstag 06.06. 15:00 - 17:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Information
Ziele, Inhalte und Methode der Lehrveranstaltung
Students will work in small teams on case studies to conceptualise concrete drug development project proposals, discuss the case study topics and revise their proposals with the supervisors. The case study will involve a real project conducted in industry. The outcomes from the industry research project will be revealed in the final lecture. The course will consist of Introduction to the course, two lectures, 3 assignments, and 3 feedback/discussion teaching sessions.
Art der Leistungskontrolle und erlaubte Hilfsmittel
Students must attend all sessions and actively participate in the discussion, complete and submit all of the assignments on time. They are expected to incorporate feedback and discussion outcomes into their revised final project proposal that is due before the last day of class.
Mindestanforderungen und Beurteilungsmaßstab
Enrollment in the Master of Drug Discovery and Development program. Successful completion of MPS1 in the Master of Drug Discovery and Development program. Course attendance; completion of assignments including revisions from feedback sessions to be submitted to instructors for evaluation. Final presentation to be submitted and given on last day of course and final revised proposal to be submitted to instructors.
Prüfungsstoff
Team presentation of the finalized project proposal (each team member must present)
Submission of the finalized research proposal and presentation slide deck.
Submission of the finalized research proposal and presentation slide deck.
Literatur
To be given in class
Zuordnung im Vorlesungsverzeichnis
Letzte Änderung: Do 26.01.2023 11:50